Amyloid β<sub>42</sub>Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1

Yingying Le(Laboratory of Molecular Genetics), Wanghua Gong(Science Applications International Corporation (United States)), H. Lee Tiffany(National Institutes of Health), Alexei V. Tumanov(Laboratory of Molecular Genetics), Sergei A. Nedospasov(Laboratory of Molecular Genetics), Weiping Shen(Laboratory of Molecular Genetics), Nancy M. Dunlop(Laboratory of Molecular Genetics), Ji‐Liang Gao(National Institutes of Health), Philip M. Murphy(National Institutes of Health), Joost J. Oppenheim(Laboratory of Molecular Genetics), Jiming Wang(Laboratory of Molecular Genetics)
Journal of Neuroscience
January 15, 2001
Cited by 271Open Access
Full Text

Abstract

Amyloid beta (Abeta) is a major contributor to the pathogenesis of Alzheimer's disease (AD). Although Abeta has been reported to be directly neurotoxic, it also causes indirect neuronal damage by activating mononuclear phagocytes (microglia) that accumulate in and around senile plaques. In this study, we show that the 42 amino acid form of beta amyloid peptide, Abeta(42), is a chemotactic agonist for a seven-transmembrane, G-protein-coupled receptor named FPR-Like-1 (FPRL1), which is expressed on human mononuclear phagocytes. Moreover, FPRL1 is expressed at high levels by inflammatory cells infiltrating senile plaques in brain tissues from AD patients. Thus, FPRL1 may mediate inflammation seen in AD and is a potential target for developing therapeutic agents.


Related Papers